Harmony Issuance Of Capital Stock from 2010 to 2024

HRMY Stock  USD 34.67  1.08  3.02%   
Harmony Biosciences Issuance Of Capital Stock yearly trend continues to be fairly stable with very little volatility. Issuance Of Capital Stock is likely to outpace its year average in 2024. During the period from 2010 to 2024, Harmony Biosciences Issuance Of Capital Stock regression line of annual values had r-squared of  0.000048 and arithmetic mean of  30,149,360. View All Fundamentals
 
Issuance Of Capital Stock  
First Reported
2010-12-31
Previous Quarter
-408 K
Current Value
-387.6 K
Quarterly Volatility
35 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Harmony Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Harmony Biosciences' main balance sheet or income statement drivers, such as Tax Provision of 28.4 M, Depreciation And Amortization of 14.7 M or Interest Expense of 17.9 M, as well as many indicators such as Price To Sales Ratio of 3.14, Dividend Yield of 0.0 or PTB Ratio of 4.32. Harmony financial statements analysis is a perfect complement when working with Harmony Biosciences Valuation or Volatility modules.
  
Check out the analysis of Harmony Biosciences Correlation against competitors.

Latest Harmony Biosciences' Issuance Of Capital Stock Growth Pattern

Below is the plot of the Issuance Of Capital Stock of Harmony Biosciences Holdings over the last few years. It is Harmony Biosciences' Issuance Of Capital Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Harmony Biosciences' overall financial position and show how it may be relating to other accounts over time.
Issuance Of Capital Stock10 Years Trend
Very volatile
   Issuance Of Capital Stock   
       Timeline  

Harmony Issuance Of Capital Stock Regression Statistics

Arithmetic Mean30,149,360
Geometric Mean13,054,541
Coefficient Of Variation116.21
Mean Deviation18,310,571
Median25,000,000
Standard Deviation35,035,442
Sample Variance1227.5T
Range148M
R-Value(0.01)
Mean Square Error1321.8T
R-Squared0.000048
Significance0.98
Slope(54,419)
Total Sum of Squares17184.8T

Harmony Issuance Of Capital Stock History

2024-387.6 K
2023-408 K
2022408 K
202130 M
2020147.6 M
201950 M

About Harmony Biosciences Financial Statements

Harmony Biosciences investors use historical fundamental indicators, such as Harmony Biosciences' Issuance Of Capital Stock, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Harmony Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Issuance Of Capital Stock-408 K-387.6 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Harmony Stock Analysis

When running Harmony Biosciences' price analysis, check to measure Harmony Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harmony Biosciences is operating at the current time. Most of Harmony Biosciences' value examination focuses on studying past and present price action to predict the probability of Harmony Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harmony Biosciences' price. Additionally, you may evaluate how the addition of Harmony Biosciences to your portfolios can decrease your overall portfolio volatility.